XML 149 R42.htm IDEA: XBRL DOCUMENT v3.25.1
Contingencies and commitments (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 31, 2014
Contingencies and Commitments [Line Items]          
Fair value of contingent consideration $ 10,524 $ 10,225 $ 7,780 $ 7,600  
Recurring          
Contingencies and Commitments [Line Items]          
Fair value of contingent consideration 10,524 $ 10,225      
Enantigen's Selling Shareholders | Recurring          
Contingencies and Commitments [Line Items]          
Fair value of contingent consideration $ 10,500       $ 0
Enantigen's Selling Shareholders | Arbutus Inc.          
Contingencies and Commitments [Line Items]          
Development and regulatory milestones payment per licensed compound series, maximum         102,500
Development and regulatory milestones payment per royalty, maximum         $ 1,000